-
PTC-028
- names:
PTC-028
- CAS号:
1782970-28-8
MDL Number: - MF(分子式): C19H12F5N5 MW(分子量): 405.32
- EINECS: Reaxys Number:
- Pubchem ID: Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|---|---|---|---|---|---|---|---|
| YZM001387-10mg | 10mg | >98.0% | ¥ 2430.00 | ¥ 2430.00 | 2-3天 | ¥ 0.00 | ||
| YZM001387-5mg | 5mg | >98.0% | ¥ 1430.00 | ¥ 1430.00 | 2-3天 | ¥ 0.00 |
| 中文别名 | |
| 英文别名 | PTC-028 |
| CAS号 | 1782970-28-8 |
| Inchi | |
| InchiKey | |
| 分子式 Formula | C19H12F5N5 |
| 分子量 Molecular Weight | 405.32 |
| 溶解度Solubility | 生物体外In Vitro:DMSO溶解度125 mg/mL(308.40 mM;Need ultrasonic)H2O< 0.1 mg/mL(insoluble) |
| 性状 | |
| 储藏条件 Storage conditions | 粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 | |
| Introduction | PTC28 is an orally bioavailable inhibitor of stem cell factorBMIin ovarian cancer. PTC28 selectively inhibits cancer cells whereas normal cells remain unaffected. Depletion of BMI by PTC28 induces caspaseediatedapoptosis. |
| Application1 | |
| Application2 | |
| Application3 |
PTC-028 是一种有效的口服有效的干细胞因子BMI-1的抑制剂,可用于治疗卵巢癌。PTC-028 选择性地抑制癌细胞,而正常细胞不受影响。PTC-028 对 BMI-1 的作用可诱导 caspase 介导的细胞凋亡 (apoptosis)。PTC-028 is an orally bioavailable inhibitor of stem cell factorBMI-1in ovarian cancer. PTC-028 selectively inhibits cancer cells whereas normal cells remain unaffected. Depletion of BMI-1 by PTC-028 induces caspase-mediatedapoptosis[1].
【1】.Dey A, et al. Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther. 2018 Jan;17(1):39-49.
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


